Medication Shortages: How to Manage When Drugs Aren't Available

GeniusRX: Your Pharmaceutical Guide

Medication Shortage Impact Calculator

Shortage Impact Calculator

Estimate treatment delays, errors, and costs when critical medications are unavailable. Based on data from the FDA and healthcare studies.

days

When your hospital runs out of morphine, or your cancer patient can’t get their IV antibiotic, you don’t get a warning. You just wake up to a phone call: medication shortages have hit again. No notice. No backup. Just silence where a life-saving drug should be.

This isn’t rare. In 2022, the U.S. faced 287 drug shortages-almost one every day. And it’s not just obscure meds. The most common are the basics: saline bags, morphine, antibiotics, chemotherapy drugs, and IV nutrition. These aren’t luxury items. They’re what keep people alive in ICUs, ERs, and outpatient clinics. And when they disappear, the ripple effect hits everyone-from nurses working 12-hour shifts just to find a substitute, to patients waiting hours longer for treatment, to families wondering why their loved one’s care was delayed.

Why Do Medication Shortages Keep Happening?

The root cause isn’t one thing. It’s a chain of broken incentives and fragile systems. Over 60% of all drug shortages involve generic sterile injectables-cheap, high-volume drugs made in just a few factories. And those factories? Most are overseas. About 80% of the active ingredients in U.S. drugs come from China and India. One quality issue at a single plant can shut down supply for months.

Manufacturers don’t make much profit on generics. A vial of morphine might cost 25 cents to produce but sell for $1. When a factory has to upgrade equipment to meet FDA standards, it’s expensive. And because Medicaid and 340B programs cap reimbursements, companies can’t raise prices to cover the cost. So they cut corners. Or worse-they stop making it altogether.

Then there’s the lack of backup. Only three companies make 75% of the IV antibiotics used in U.S. hospitals. No redundancy. No safety net. And the system doesn’t force them to plan ahead. The FDA asks manufacturers to report potential shortages, but only 65% do it on time. That means hospitals often find out a drug is gone when their order doesn’t arrive.

What Happens When a Drug Disappears?

It’s not just about swapping one pill for another. Every substitution carries risk.

Take morphine. When it’s unavailable, hospitals turn to hydromorphone. It’s stronger. Dosing is trickier. One study found medication errors jumped 15% during these switches. Nurses who’ve been giving morphine for years suddenly have to calculate new infusion rates. Pharmacists scramble to retrain staff. And patients? They get confused. They feel less pain relief. Or worse-they get too much and stop breathing.

On the nursing floor, delays pile up. The average patient waits 22 extra minutes for their critical medication during a shortage. That’s not just inconvenience. In sepsis or cardiac arrest, minutes matter. One nurse in Texas told the American Journal of Nursing she had to delay a life-saving antibiotic for 90 minutes because the pharmacy couldn’t find any. The patient survived-but barely.

And it’s not just hospitals. Primary care clinics report 84% had at least one drug shortage in the past year. Forty-three percent say it changed how they treated patients. Some delayed cancer treatments. Others switched to less effective oral drugs when IV was needed. One doctor in rural Ohio told me his clinic had to stop giving insulin glargine for six weeks. Patients had to use older, less stable insulin. Blood sugars spiked. Two ended up in the ER.

How Hospitals Are Trying to Cope

Some hospitals are getting smarter. They’re not waiting for the phone to ring. They’re building teams.

A good shortage response team includes: a pharmacist who tracks inventory daily, a nurse who maps out workflow disruptions, a finance person who knows which alternatives are covered by insurance, an IT specialist who logs every error, and a communications lead who tells staff and patients what’s happening-fast.

These teams meet weekly. When a shortage hits, they convene within four hours. They don’t just guess what to do. They check: Is there an alternative? Is it FDA-approved for this use? Is it safe for elderly patients? Is it covered by Medicaid? Then they document it all.

They also keep buffer stock. The American Society of Health-System Pharmacists recommends 14 to 30 days of critical drugs on hand. But only 35% of hospitals can afford that. Safety-net hospitals-those serving low-income patients-often have just 8 to 12 days. That’s not a buffer. That’s a countdown.

Some are using real-time dashboards. One hospital in Minnesota tracks every vial of vancomycin, morphine, and propofol in its system. When stock drops below 10%, it auto-alerts the pharmacy. That’s not magic. It’s basic inventory control. But most hospitals still use spreadsheets.

Medical team using a whiteboard to map drug alternatives during a shortage, sticky notes and arrows everywhere.

What Patients and Families Can Do

You can’t fix the supply chain. But you can protect yourself.

  • Ask your doctor: Is this medication on shortage? If yes, ask: What’s the backup? Is it safe for me?
  • If you’re on a long-term drug like insulin, levothyroxine, or blood pressure meds, ask for a 90-day supply. It gives you breathing room if a shortage hits.
  • Don’t switch medications on your own. A substitute might look similar, but it could interact with your other drugs or worsen your condition.
  • Keep a list of all your meds-including dosages and why you take them. If your pharmacy runs out, you can show your doctor exactly what you need.
  • Call your pharmacy ahead of time. If they’re out of your drug, they might know where to get it-or have an alternative ready.

And if you’re told your treatment is delayed? Ask why. Push for a written explanation. You have the right to know what’s happening to your care.

The Bigger Picture: Why This Isn’t Just a Pharmacy Problem

This isn’t just about pills. It’s about how we value health care.

The U.S. pays less for generic drugs than almost any other wealthy country. But we expect the same quality. We don’t pay manufacturers enough to invest in reliable production. We don’t require them to have backup suppliers. We don’t stockpile critical drugs like we do for vaccines or bioterrorism threats.

Compare that to Germany. They keep national stockpiles of 30 essential drugs. When a shortage hits, they release them to hospitals. Result? 52% fewer disruptions.

France and Canada have mandatory reporting. Manufacturers must notify regulators 6 months before a potential shortage. That gives hospitals time to plan. In the U.S., we wait until the drug is already gone.

And the cost? Hospitals spend an average of $218,000 per drug shortage managing the chaos-staff overtime, emergency orders, error tracking, training. That’s $1.2 billion a year. That’s money that could be spent on hiring nurses, upgrading equipment, or expanding care.

Family in clinic waiting room with medication list, doctor pointing to an empty insulin vial on a chart.

What’s Changing? And What Could Help?

There are signs of movement.

In 2022, the Department of Health and Human Services created a new role: Supply Chain Resilience and Shortage Coordinator. Their job? To make agencies talk to each other. They’ve started building a response framework. It’s early, but it’s a start.

The FDA is also pushing manufacturers to create Risk Management Plans. These must include: where their ingredients come from, what happens if a supplier fails, and how they’ll alert the FDA before a shortage hits. If finalized in 2024 as expected, this could cut delays by 25%.

Some experts want Medicare to pay more for drugs made by reliable manufacturers. Reward quality, not just low price. That could push companies to invest in better equipment and backup systems. One estimate says this could unlock $1.5 billion in new investment.

Long-term, advanced manufacturing-like small, flexible production lines that can switch between drugs in hours instead of weeks-could cut shortages by 40%. But that requires federal funding and industry buy-in. So far, it’s still a proposal.

Without change, shortages will grow 8% to 12% each year through 2030. Oncology drugs, anesthesia agents, and critical care meds will be hit hardest. That means more delays. More errors. More lives at risk.

What You Can Do Now

You don’t need to wait for Congress to fix this. Start with what’s in your control.

  • If you’re a patient: Stay informed. Ask questions. Advocate for yourself.
  • If you’re a caregiver: Keep a written list of meds. Know the alternatives.
  • If you’re a provider: Build a team. Document everything. Train your staff.
  • If you’re a policymaker: Support mandatory reporting. Fund stockpiles. Reward quality over cheapness.

Medication shortages aren’t inevitable. They’re the result of choices we’ve made-and choices we can change. But right now, the system is broken. And people are paying the price.

Don’t wait for the next shortage to hit before you act. Know your meds. Know your options. Speak up.

What are the most common drugs in shortage right now?

The most common drugs in shortage are generic sterile injectables-especially IV antibiotics like vancomycin and piperacillin-tazobactam, pain meds like morphine and fentanyl, anesthesia agents like propofol, chemotherapy drugs like doxorubicin, and IV fluids like normal saline and dextrose. These are the backbone of emergency and hospital care. In 2022, 63% of all shortages were in this category, according to FDA data.

Can I switch to a different brand if my drug is unavailable?

Sometimes, but not always. Generic drugs are required to be bioequivalent, but substitutes aren’t always interchangeable in practice. For example, switching from one brand of insulin to another can cause blood sugar swings. IV medications are even trickier-different formulations can cause allergic reactions or affect absorption. Always consult your doctor or pharmacist before switching. Never self-substitute.

Why don’t pharmacies just order more when they see a shortage coming?

Because they often don’t know it’s coming. Manufacturers aren’t required to give early notice in the U.S., and only 65% report potential shortages voluntarily. By the time a pharmacy finds out, the drug is already sold out nationwide. Even if they knew, many can’t afford to stockpile. Buffer inventories cost money-and most pharmacies operate on thin margins.

Are there any safe alternatives to drugs in shortage?

Yes, but they’re not always easy to find. For morphine, hydromorphone is a common substitute-but it’s 5 to 10 times stronger, so dosing must be precise. For saline, some hospitals use oral rehydration or adjust IV rates. For antibiotics, oral versions might be used if appropriate. But alternatives aren’t always as effective, especially in critical cases. The key is having a clinical team that can evaluate each option safely and document the decision.

How long do drug shortages usually last?

The average shortage lasts 9.8 months, up from 6.2 months in 2015. Oncology drugs often last the longest-up to 14.3 months. Some shortages resolve in weeks if a factory fixes its quality issue. Others take over a year if production must be restarted from scratch or if new suppliers are needed. There’s no reliable timeline, which makes planning nearly impossible.

Written by Sara Hooshyar

I work as a pharmacist specializing in pharmaceuticals, and I'm passionate about writing to educate people on various aspects of medications. My job allows me to stay at the forefront of the latest advancements in pharmaceuticals, and I derive immense satisfaction from sharing my knowledge with a broader audience.

Elizabeth Choi

Just saw the FDA’s latest report - 42 new shortages in the last month alone. Most are sterile injectables. No one’s talking about how this is systematically crushing rural hospitals. They don’t have the staff or budget to build response teams like the big city ones. They just pray the pharmacy has a vial left.

Allison Turner

Another day, another drug gone. Nurses are tired. Patients are scared. And the CEOs? Still getting bonuses. It’s not a crisis - it’s a business model.